Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Iscador U c. Hg is an anthroposophic medicinal product consisting of a fermented aqueous extract of European mistletoe (*Viscum album* L.) harvested from elm trees (*Ulmus*), supplemented with homeopathically diluted mercury sulfate (D8). Developed by Iscador AG and manufactured at the Hiscia Institute, it is used as an integrative or complementary therapy for both malignant and benign tumors. The preparation is administered via subcutaneous injection and is intended to exert immunomodulatory and cytotoxic effects, stimulating the immune system and inducing apoptosis in cancer cells. It is part of a broader range of mistletoe preparations used in anthroposophic medicine since the 1920s, with each variant defined by the host tree from which the mistletoe is harvested.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Iscador U c. Hg.